Advanced Search


Study ID Status Title Patient Level Data
200587 Completed An Open Label, Randomised, Four-Period Crossover, Single Dose Study in Healthy Volunteers to Evaluate the Pharmacokinetics of FF/UMEC/VI Combination Administered at Dose Levels 100/62.5/25 mcg and 100/125/25 mcg and in Comparison with FF/VI (100/25 mcg) and UMEC/VI (62.5/25 mcg). Study Listed on
200591 Completed A Single-Center In Vitro Study to Evaluate GSK1325756 Inhibition of CD11b Cell Surface Expression in Healthy Adults and Respiratory Syncytial Virus-Infected Children <2 Years (200591)
200592 Terminated Single-blind, randomised, placebo-controlled study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of repeat doses of GSK2647544 and its potential pharmacokinetic interaction with simvastatin in healthy volunteers Study Listed on
200600 Completed Evaluation of clinical and economic benefits of fluticasone furoate compared with mometasone furoate and budesonide in the treatment of allergic rhinitis
200606 Active, Not Recruiting Risk of Adverse Events and Costs Associated with Chronic Systemic Corticosteroid Use in UK Patients with Severe Asthma
200612 Completed A protocol to collect human serum samples from healthy adults
200613 Completed An observer-blind study to evaluate the safety and immunogenicity of GSK Biologicals’ influenza vaccine(s) GSK2789869A administered in adults 65 years of age and older
200619 Active, Not Recruiting A Meta-analysis Evaluation of Baseline Factors Which Correlate with High Baseline BLyS Levels (>2ng/mL) (BLISS-52 & BLISS 76)
200632 Completed PGX6847: Exploratory PGx investigation of dabrafenib efficacy in melanoma monotherapy studies BRF113710, BRF113929, and BRF113683
200633 Completed PGX6848: Exploratory PGx investigation of trametinib efficacy in a melanoma monotherapy study MEK114267
200638 Completed Contac Bien Z Adverse Effect Survey
200638 Completed Contac Bien Z Adverse Effect Survey
200697 Completed A Single-Dose, Open-Label, Randomized, Parallel-Group Study to Demonstrate the Bioequivalence of Lamotrigine Dispersible/Chewable Tablet (100mg) and Lamotrigine Compressed Tablet (100mg) in Healthy Chinese Male Subjects Study Listed on
200699 Completed 200699: A Clinical Study to Evaluate Four Doses of Umeclidinium Bromide in Combination with Fluticasone Furoate in COPD Subjects with an Asthmatic Component
2006-Analysis Completed Paroxetine Adult Suicidality Analysis (2006 Dataset)
200713 Not yet recruiting Characteristics of out-patients with epilepsy and patterns of antiepileptic drug utilisation in neurology department at tertiary hospitals: A Cross-Sectional Study in China
200725 Not yet recruiting TENOZET® Drug Use Investigation
200726 Active, Not Recruiting TENOZET® Special Drug Use Investigation
200773 Completed Pazopanib Sarcoma Named Patient Programme Chart Review
200775 Completed Dabrafenib Melanoma Named Patient Programme Chart Review
200776 Completed Valproate dose reduction and its clinical evaluation by introducing lamotrigine in Japanese women with epilepsy – single arm, multicenter, and open-label study – Study Listed on
200784 Completed A Phase 1, Randomized, Double-Blind (sponsor open), Placebo-Controlled, Single Dose Escalation Trial to Evaluate the Safety, Tolerability Pharmacokinetics and Pharmacodynamics of GSK3050002 (anti-CCL20 monoclonal antibody) in Healthy Male Volunteers
200791 Completed Clinical Pharmacology Reporting and Analysis Plan for a Combined Analyses to Evaluate the Effect of Ofatumumab on Cardiac Repolarization (QTc Duration)
200793 Completed TOCTINO® for severe chronic hand eczema – post observation of successful treated patients in TOCCATA
200794 Completed A Pilot Study to Measure Force Recovery and Protein Synthetic Rates After Unilateral Eccentric Exercise in Healthy Males Volunteers Unaccustomed to Eccentric Exercise



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.